Markets

--Analyst Actions: Wedbush Trims TCR2 Therapeutics' Price Target to $25 From $28, Keeps Outperform Rating

11:48AM ET 11/12/2019 MT Newswires

Price: 15.10, Change: +0.32, Percent Change: +2.17